| Authors: |
Srinivasan R; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, Collegeville, PA, USA., Angulo FJ; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, Collegeville, PA, USA., Duench S; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, New York, NY, USA., Davidson A; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, New York, NY, USA., Kelly PH; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, New York, NY, USA., Riddle MS; Vaccine Research Development, Pfizer, Pearl River, NY, USA., Halsby K; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, Walton Oaks, UK., Pilz A; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, Vienna, Austria., Steffen R; Epidemiology, Biostatistics and Prevention Institute. WHO Collaborating Centre for Traveler's Health, University of Zurich, Zurich, Switzerland.; Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas, School of Public Health, Houston, TX, USA., Stark JH; Global Vaccines and Anti-Infectives Medical Affairs, Pfizer, Cambridge, MA, USA. |
